Search
Searching Content indexed under Healthcare by Phillip Bradley ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Patients' Voices Carry: Drug Development Increasingly Driven By Patients' Needs And Concerns
With the recent announcement of Sarepta's filing for approval of its drug, eteplirsen, for the treatment of Duchenne muscular dystrophy (DMD), it has become clear that the role of patient advocates and patient-centered outcomes has had a significant favorable impact both upon the FDA and the development of products for rare diseases.
United States
27 Jul 2015
2
When It Comes To Personalized Medicine (Or Precision Medicine!), There Seem To Be More Questions Than Answers
There is general recognition that as medicine becomes more tailored to the individual—whether through tumor analysis, pathogen sensitivity testing, or predicted drug response—cost of care and cost per treatment will rise...
United States
16 Jul 2015
Links to Result pages
 
1